Cytoprotectieve effects of rebamipide and carteolol hydrochloride against ultraviolet B-induced corneal damage in mice
Cytoprotectieve effects of rebamipide and carteolol hydrochloride against ultraviolet B-induced corneal damage in mice
复制标题
DOI:
10.1167/iovs.02-1043
复制
发表时间:
2003-07-01
影响因子:
4.4
通讯作者:
Ohira, A
中科院分区:
文献类型:
--
作者:
Tanito, M;Takanashi, T;Ohira, A
PURPOSE. To analyze whether rebamipide (REB) and carteolol hydrochloride (CH) protect against UVB-induced corneal damage in mice.METHODS. BALB/c mice topically pretreated with REB (1 and 10 mM) or CH (1, 10, and 100 mM) were exposed to ultraviolet (UV) B light at 416 muW/cm(2). To evaluate corneal damage, mire irregularity was graded, and the haze index was estimated by using digitized corneal images. The formation of oxidized DNA in the corneal epithelium resulting from UVB exposure was estimated by using quantitative immunohistochemistry for 8-hydroxy-2-deoxyguanosine (80HdG index). To analyze the mechanism of cytoprotection by REB and CH against UVB-induced cell damage, the UV absorption spectrum in these agents was evaluated by spectrophotometry, and their hydroxyl radical scavenging effect was evaluated by the electron spin resonance (ESR) spin trapping technique with Fenton system hydroxy radical generation.RESULTS. Seventy-two hours after UVB exposure, the severity of mire irregularity, haze index, and 80HdG index were significantly lower in mice pretreated with 10 mM (P < 0.05, P < 0.05, and P < 0.01, respectively) of REB and in mice pretreated with 10 mM (P < 0.05, P < 0.01, and P < 0.01, respectively) and 100 mM (P < 0.01, P < 0.01, and P < 0.01, respectively) of CH compared with mice treated with vehicle. The absorption spectrum of REB overlapped with the UVB wavelength, and that of CH overlapped partially. The ESR spin signal corresponding to the hydroxyl radical was reduced by the addition of REB or CH.CONCLUSIONS. REB and CH attenuate UVB-induced corneal damage, which may be partly responsible for their sunscreening and hydroxyl radical scavenging effects. (Invest Ophthalmol Vis Sci. 2003;44:2980-2985) DOI: 10.1167/iovs-02-1043.